Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Determine the index fund with the lowest retirement cost through a concise comparison to guide a cost-aware choice.
28,256 articlesViking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Verizon sits near a 52-week high while AT&T hovers around a key level near $23, prompting renewed investor scrutiny o...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Dennis Quaid has listed his Los Angeles residence for $5.2 million as he relocates to Nashville, a move that highligh...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...
The Federal Communications Commission announced an enforcement action against The View over possible equal-time viola...
Newmont released after-hours results, signaling steady production yet revenue depends on gold prices. The company gui...
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
Explore the 2026 earnings outlook for Quanex (NX) with a clear, investor-friendly analysis. Learn what drives results...
Mastercard and Visa dominate the card networks landscape, but they differ in growth levers, risk, and returns. This g...
As the AI boom accelerates, the inference layer becomes the engine. This article explains why artificial intelligence...